Literature DB >> 22821198

The effects of homocysteine-related compounds on cardiac contractility, coronary flow, and oxidative stress markers in isolated rat heart.

Vladimir Zivkovic1, Vladimir Jakovljevic, Dusica Djordjevic, Milena Vuletic, Nevena Barudzic, Dragan Djuric.   

Abstract

Research on the effects of homocysteine on the vascular wall, especially in endothelial and smooth muscle cells, has indicated that increased homocysteine levels lead to cellular stress and cell damage. Considering the adverse effects of homocysteine on vascular function and the role of oxidative stress in these mechanisms, the aim of this study was to estimate the influence of different homocysteine isoforms on cardiac contractility, coronary flow, and oxidative stress markers in isolated rat heart. The hearts of male Wistar albino rats (n = 36, age 8 weeks, body mass 180-200 g), were excised and retrogradely perfused according to the Langendorff technique at a constant perfusion pressure (70 cmH(2)O) and administered with three isoforms of 10 μM homocysteine [DL-Hcy, DL-Hcy thiolactone-hydrochloride (TLHC) and L-Hcy TLHC). After the insertion and placement of the sensor in the left ventricle, the parameters of heart function: maximum rate of pressure development in the left ventricle (dP/dt max), minimum rate of pressure development in the left ventricle (dP/dt min), systolic left ventricular pressure (SLVP), diastolic left ventricular pressure (DLVP), mean blood pressure (MBP) and heart rate (HR)] were continuously registered. Flowmetry was used to evaluate the coronary flow. Markers of oxidative stress: index of lipid peroxidation measured as TBARS, nitric oxide measured through nitrites (NO(2)(-)), superoxide anion radical (O(2)(-)), and hydrogen peroxide (H(2)O(2)) in the coronary venous effluent were assessed spectrophotometrically. Our results showed that administration of Hcy compounds in concentration of 10 μM induced depression of cardiac contractility, manifested by a decrease in dp/dt max after administration of any Hcy compound, decrease in dp/dt min after administration of L-Hcy TLHC, decrease in SLVP after administration of DL-Hcy TLHC and DL-Hcy, and the drop in CF after administration of any Hcy compound. Regarding the effects of Hcy on oxidative stress parameters, only L-Hcy TLHC significantly affected O(2)(-) release. L-Hcy TLHC showed a cardiotoxic effect by affecting heart contractility, but surprisingly, it decreased the release of O(2)(-).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22821198     DOI: 10.1007/s11010-012-1398-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  52 in total

Review 1.  Homocysteine metabolism.

Authors:  J Selhub
Journal:  Annu Rev Nutr       Date:  1999       Impact factor: 11.848

Review 2.  Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.

Authors:  Earl S Ford; S Jay Smith; Donna F Stroup; Karen K Steinberg; Patricia W Mueller; Stephen B Thacker
Journal:  Int J Epidemiol       Date:  2002-02       Impact factor: 7.196

3.  Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.

Authors:  S R Lentz; C G Sobey; D J Piegors; M Y Bhopatkar; F M Faraci; M R Malinow; D D Heistad
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

4.  Generation of nitrotyrosine precedes activation of metalloproteinase in myocardium of hyperhomocysteinemic rats.

Authors:  Harpreet S Sood; Michael J Cox; Suresh C Tyagi
Journal:  Antioxid Redox Signal       Date:  2002-10       Impact factor: 8.401

Review 5.  Putative mechanisms for vascular damage by homocysteine.

Authors:  M F Bellamy; I F McDowell
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

6.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Authors: 
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

7.  Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.

Authors:  S R Lentz; M R Malinow; D J Piegors; M Bhopatkar-Teredesai; F M Faraci; D D Heistad
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

8.  Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats.

Authors:  Amanda Miller; Vibhas Mujumdar; Lena Palmer; John D Bower; Suresh C Tyagi
Journal:  Am J Hypertens       Date:  2002-02       Impact factor: 2.689

9.  Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1.

Authors:  Karni S Moshal; Munish Kumar; Neetu Tyagi; Paras K Mishra; Naira Metreveli; Walter E Rodriguez; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

10.  Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.

Authors:  P Holvoet; J Vanhaecke; S Janssens; F Van de Werf; D Collen
Journal:  Circulation       Date:  1998-10-13       Impact factor: 29.690

View more
  11 in total

1.  Effects of homocysteine and its related compounds on oxygen consumption of the rat heart tissue homogenate: the role of different gasotransmitters.

Authors:  Jovana Jakovljević Uzelac; Marina Stanić; Danijela Krstić; Mirjana Čolović; Dragan Djurić
Journal:  Mol Cell Biochem       Date:  2017-11-29       Impact factor: 3.396

2.  Effects of mild hyperhomocysteinemia on electron transport chain complexes, oxidative stress, and protein expression in rat cardiac mitochondria.

Authors:  Veronika Timkova; Zuzana Tatarkova; Jan Lehotsky; Peter Racay; Dusan Dobrota; Peter Kaplan
Journal:  Mol Cell Biochem       Date:  2015-10-15       Impact factor: 3.396

3.  Adaptive regulation of riboflavin transport in heart: effect of dietary riboflavin deficiency in cardiovascular pathogenesis.

Authors:  Tamilarasan Udhayabanu; Sellamuthu Karthi; Ayyavu Mahesh; Perumal Varalakshmi; Andreea Manole; Henry Houlden; Balasubramaniem Ashokkumar
Journal:  Mol Cell Biochem       Date:  2017-08-23       Impact factor: 3.396

4.  The effects of the modulation of NMDA receptors by homocysteine thiolactone and dizocilpine on cardiodynamics and oxidative stress in isolated rat heart.

Authors:  Ivan Srejovic; Vladimir Jakovljevic; Vladimir Zivkovic; Nevena Barudzic; Ana Radovanovic; Olivera Stanojlovic; Dragan M Djuric
Journal:  Mol Cell Biochem       Date:  2014-12-03       Impact factor: 3.396

5.  Effect of hyperhomocysteinemia on rat cardiac sarcoplasmic reticulum.

Authors:  Zuzana Tatarkova; Maria Bencurova; Jan Lehotsky; Peter Racay; Monika Kmetova Sivonova; Dusan Dobrota; Peter Kaplan
Journal:  Mol Cell Biochem       Date:  2022-02-27       Impact factor: 3.396

Review 6.  Pioglitazone and Endothelial Dysfunction: Pleiotropic Effects and Possible Therapeutic Implications.

Authors:  Miroslav Radenković
Journal:  Sci Pharm       Date:  2014-08-18

7.  Effects of DL-homocysteine thiolactone on cardiac contractility, coronary flow, and oxidative stress markers in the isolated rat heart: the role of different gasotransmitters.

Authors:  Vladimir Zivkovic; Vladimir Jakovljevic; Olga Pechanova; Ivan Srejovic; Jovana Joksimovic; Dragica Selakovic; Nevena Barudzic; Dragan M Djuric
Journal:  Biomed Res Int       Date:  2013-11-24       Impact factor: 3.411

8.  Dietary methionine restriction in mice elicits an adaptive cardiovascular response to hyperhomocysteinemia.

Authors:  Gene P Ables; Amadou Ouattara; Thomas G Hampton; Diana Cooke; Frantz Perodin; Ines Augie; David S Orentreich
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

9.  The Role of Cardiac N-Methyl-D-Aspartate Receptors in Heart Conditioning-Effects on Heart Function and Oxidative Stress.

Authors:  Natalia Govoruskina; Vladimir Jakovljevic; Vladimir Zivkovic; Isidora Milosavljevic; Jovana Jeremic; Jovana Bradic; Sergey Bolevich; Israpil Alisultanovich Omarov; Dragan Djuric; Katarina Radonjic; Marijana Andjic; Nevena Draginic; Aleksandra Stojanovic; Ivan Srejovic
Journal:  Biomolecules       Date:  2020-07-16

10.  Cardiac peroxisome proliferator-activated receptor δ (PPARδ) as a new target for increased contractility without altering heart rate.

Authors:  Zhih-Cherng Chen; Kung Shing Lee; Li-Jen Chen; Lin-Yu Wang; Ho-Shan Niu; Juei-Tang Cheng
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.